Two Cannabis Companies Cease Production Of Certain Extracts Due To Inaccurate Classification
Health Canada notified two cannabis businesses on improper product classification.
Maximize Your Returns: Get To Know The Top Performing Cannabis Stocks Of The Last 12 Months
The past 12 months have been a wild ride for both investors and cannabis shareholders, as evidenced by big rallies as well as steep declines.
Latest Executive Changes In Marijuana Industry, New Appointments & More
As the Benzinga Cannabis Capital Conference returns to Miami (April 11-12), gathering top CEOs, investors and leaders in the mari
Organigram Q4 Revenue Grows 83% YoY, Provides Outlook
Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI) released its results for the fourth quarter and year ended August 31, 2022, revealing net revenue in FY 2022 increased 84% to $145.8 million from $79.2 million in the previous year primarily due to an increase in recreational
Organigram Launches Holy Mountain Cannabis Brand Focusing On Value Whole Flower And Hash Categories
Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI) launched HOLY MOUNTAIN, the company’s newest value brand featuring an initial lineup of dried flower strains and entering the market with value pressed hash.
Cannabis Legalization In Germany And Thailand, Gray Market In Brooklyn, Craft Weed Companies In Oregon
German Opposition Official Against Recreational Marijuana Legalization Plan
This Analyst Expects Stabilization Across Canadian Cannabis Market, Revises Sales Estimates For Cannabis LPs
The Canadian cannabis industry has become a competitive field over the past few years, which doesn’t come as a surprise considering its exponential growth over the same period.
Cantor Fitzgerald Maintains Overweight on OrganiGram Holdings, Lowers Price Target to C$2.9
Cantor Fitzgerald analyst Pablo Zuanic maintains OrganiGram Holdings (TSX:OGI) with a Overweight and lowers the price target from C$3.7 to C$2.9.
Cantor Fitzgerald Maintains Overweight on OrganiGram Holdings, Lowers Price Target to C$3.7
Cantor Fitzgerald analyst Pablo Zuanic maintains OrganiGram Holdings (TSX:OGI) with a Overweight and lowers the price target from C$5.3 to C$3.7.
Why Organigram Shares Are Trading Higher Today? Posts Record High Net Revenue In Q2, Still Among Top Canadian LPs
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of the cannabis company Organigram Inc, announced its results for the second quarter ended February 28, 2022.